{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:10:38Z","timestamp":1791893438046,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.freeradbiomed.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T17:52:56Z","timestamp":1549821176000},"page":"598-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["13-HODE, 9-HODE and ALOX15 as potential players in Rett syndrome OxInflammation"],"prefix":"10.1016","volume":"134","author":[{"given":"Alessandra","family":"Pecorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cordone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Amicarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joussef","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Valacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.freeradbiomed.2019.02.007_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00005072-199708000-00001","article-title":"Review of Rett syndrome","volume":"56","author":"Armstrong","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.biocel.2016.07.015","article-title":"OxInflammation in Rett syndrome","volume":"81","author":"Pecorelli","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cyto.2015.10.002","article-title":"Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients","volume":"77","author":"Pecorelli","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fphys.2018.00858","article-title":"OxInflammation: from subclinical condition to pathological biomarker","volume":"9","author":"Valacchi","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib7","doi-asserted-by":"crossref","first-page":"480980","DOI":"10.1155\/2014\/480980","article-title":"Subclinical inflammatory status in Rett syndrome","volume":"2014","author":"Cortelazzo","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2016.12.045","article-title":"4-hydroxynonenal protein adducts: key mediator in Rett syndrome oxinflammation.","volume":"111","author":"Valacchi","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"10 Pt A","key":"10.1016\/j.freeradbiomed.2019.02.007_bib9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bbadis.2015.07.014","article-title":"Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage","volume":"1852","author":"Cervellati","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","author":"Uchida","year":"2003","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2019.02.007_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.freeradbiomed.2006.05.020","article-title":"Oxidatively modified autoantigens in autoimmune diseases","volume":"41","author":"Kurien","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2042018810375656","article-title":"Review: hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis","author":"Vangaveti","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib13","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M700505-JLR200","article-title":"Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation","author":"Wang","year":"2009","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2019.02.007_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/jid.2010.342","article-title":"Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-Mediated activation of the NF-\u03baB signaling pathway","volume":"131","author":"Ogawa","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"18","key":"10.1016\/j.freeradbiomed.2019.02.007_bib15","first-page":"30038","article-title":"Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies","author":"Singh","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbi.2016.03.020","article-title":"9- and 13-Hydroxy-octadecadienoic acids (9+13 HODE) are inversely related to granulocyte colony stimulating factor and IL-6 in runners after 2h running","volume":"56","author":"Nieman","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib17","doi-asserted-by":"crossref","first-page":"5694058","DOI":"10.1155\/2017\/5694058","article-title":"Lactonase activity and lipoprotein-phospholipase A2as possible novel serum biomarkers for the differential diagnosis of autism spectrum disorders and Rett syndrome: results from a pilot study","volume":"2017","author":"Hayek","year":"2017","journal-title":"Oxid Med Cell Longev."},{"issue":"48","key":"10.1016\/j.freeradbiomed.2019.02.007_bib18","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1021\/bi301024e","article-title":"Specificity of lipoprotein-associated phospholipase a 2 toward oxidized phosphatidylserines: liquid chromatography\u2013electrospray ionization mass spectrometry characterization of products and computer modeling of interactions","volume":"51","author":"Tyurin","year":"2012","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib19","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170216","article-title":"Rett syndrome: a neurological disorder with metabolic components","volume":"8","author":"Kyle","year":"2018","journal-title":"Open Biol"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2019.02.007_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib21","article-title":"MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome","author":"Ciernia","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2019.02.007_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153473","article-title":"MeCP2 related studies benefit from the use of CD1 as genetic background","volume":"11","author":"Cobolli Gigli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib23","article-title":"A role for metabolism in Rett syndrome pathogenesis: new clinical findings and potential treatment targets","volume":"1","author":"Justice","year":"2013","journal-title":"Rare Dis."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2019.02.007_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104834","article-title":"Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients","volume":"9","author":"Segatto","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.freeradbiomed.2019.02.007_bib25","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.febslet.2013.05.042","article-title":"Scavenger receptor B1 post-translational modifications in Rett syndrome","volume":"587","author":"Sticozzi","year":"2013","journal-title":"FEBS Lett."},{"issue":"Pt A","key":"10.1016\/j.freeradbiomed.2019.02.007_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2016.10.021","article-title":"Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis","volume":"1654","author":"Lopez","year":"2017","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2019.02.007_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003669","article-title":"Mecp2-null mice provide new neuronal targets for Rett syndrome","volume":"3","author":"Urdinguio","year":"2008","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.freeradbiomed.2019.02.007_bib28","first-page":"3029","article-title":"MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex","volume":"25","author":"Kyle","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"Pt A","key":"10.1016\/j.freeradbiomed.2019.02.007_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2015.04.019","article-title":"Exploring the po,sible link between MeCP2 and oxidative stress in Rett syndrome","volume":"88","author":"Filosa","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"14","key":"10.1016\/j.freeradbiomed.2019.02.007_bib30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical relevance of biomarkers of oxidative stress","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"5\u20136","key":"10.1016\/j.freeradbiomed.2019.02.007_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clinbiochem.2011.01.007","article-title":"Increased levels of 4HNE-protein plasma adducts in Rett syndrome","volume":"44","author":"Pecorelli","year":"2011","journal-title":"Clin. Biochem."},{"issue":"15\u201316","key":"10.1016\/j.freeradbiomed.2019.02.007_bib32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.cca.2011.04.016","article-title":"F\u2084-neuroprostanes mediate neurological severity in Rett syndrome","volume":"412","author":"Signorini","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2019.02.007_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.plefa.2014.08.002","article-title":"Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: effects of omega-3 polyunsaturated fatty acid supplementation","volume":"91","author":"Signorini","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib34","doi-asserted-by":"crossref","first-page":"195935","DOI":"10.1155\/2014\/195935","article-title":"Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome","volume":"2014","author":"Signorini","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","article-title":"A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion","volume":"19","author":"Li","year":"1997","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neurobiolaging.2007.06.012","article-title":"Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers","volume":"30","author":"Yoshida","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2019.02.007_bib37","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.celrep.2018.04.010","article-title":"Inhibition of Gsk3b reduces Nfkb1 signaling and rescues synaptic activity to improve the Rett syndrome phenotype in mecp2-knockout mice","volume":"23","author":"Jorge-Torres","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.freeradbiomed.2019.02.007_bib38","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1038\/ncomms10520","article-title":"Reduction of aberrant NF-\u03baB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice","volume":"7","author":"Kishi","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2019.02.007_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacl.2017.02.005","article-title":"Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: a systematic review","volume":"11","author":"Younus","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"4\u20135","key":"10.1016\/j.freeradbiomed.2019.02.007_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.plefa.2012.08.004","article-title":"Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans","volume":"87","author":"Ramsden","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2019.02.007_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbagen.2011.12.002","article-title":"Morphological changes and oxidative damage in Rett Syndrome erythrocytes","volume":"1820","author":"Ciccoli","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2019.02.007_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12263-012-0285-7","article-title":"Partial rescue of Rett syndrome by \u03c9-3 polyunsaturated fatty acids (PUFAs) oil","volume":"7","author":"De Felice","year":"2012","journal-title":"Genes Nutr"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2019.02.007_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv Nutr"},{"issue":"8","key":"10.1016\/j.freeradbiomed.2019.02.007_bib44","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1194\/jlr.M900193-JLR200","article-title":"Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters","volume":"51","author":"Shearer","year":"2010","journal-title":"J. Lipid Res."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584918325413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584918325413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:07:37Z","timestamp":1760206057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584918325413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":44,"alternative-id":["S0891584918325413"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.02.007","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"13-HODE, 9-HODE and ALOX15 as potential players in Rett syndrome OxInflammation","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}